SeraCare’s SARS-CoV-2 Quality Solution

AccuPlex™ SARS-CoV-2 Reference Material, from SeraCare, is designed to measure day-to-day performance of the assay, providing both a positive and a negative reference solution. The product is available in versions that offer different SARS-CoV-2 sequence coverage: Version 1 covers the CDC and WHO consensus sequences, Version 2 has been enhanced to also include the S gene region, and Version 3 is expanded to include the full SARS‐CoV‐2 viral genome (Table 1). All products also include negative reference materials targeting the human RNase P gene.

AccuPlex™ SARS-CoV-2 Verification Panel, coupled with the AccuPlex™ SARS-CoV-2 Reference Material, is a complete Quality Solution. Both products are available in three versions with different SARS-CoV-2 sequence coverage: Version 1 covers the CDC and WHO consensus sequences, Version 2 has been enhanced to also include the S gene region, and Version 3 is expanded to include the full SARS-CoV-2 viral genome (Table 1).  All products also include negative reference materials targeting the human RNase P gene.

  • Non-infectious and replication deficient, enables safe handling of positive material
  • Fully-extractable with a real viral protein coat; serves as a full-process reference material
  • Compatible with assays targeting CDC and WHO consensus sequences
  • Includes negative reference material for targeting sequences for the human RNAse P gene
  • 2 year stability at 2 – 8°C
  • Customisable to sequences of interest to meet unique assay design requirements